This chapter includes devices that were discussed at BCAP Area Prescribing Committee and therefore relate to patients being treated within the RUH. The chapter will be reviewed by the new BSW Area Prescribing Committee.
Jaw rehabilitation (Therabite®) (Device)
Recommended for patients following head and neck radiotherapy or head and neck surgery when recommended by an appropriate Secondary Care Specialist
Only on recommendation from maxillofacial surgeon with clear follow up plan by specialist
Not recommended - limited clinical value treatment
Patients may purchase from a pharmacy or on-line directly from the manufacturers if wanted
Not recommended as the British Hypertension Society consider that the small effect over short durations do not provide sufficient evidence for this equipment to be recommended
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
High Cost Drug Approval System
Traffic Light Status Information
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.
Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.
Suitable for patient to be directed to buy themselves
Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.
Not currently used. We intend to include this TLS in future to highlight where a decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.
Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.